Have a personal or library account? Click to login
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis# Cover

Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis#

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
Volume 6 (2018): Issue 1 (June 2018)
By: Erica Ramstad,  Ole Jakob Storebø,  Trine Gerner,  Helle B. Krogh,  Mathilde Holmskov,  Frederik L. Magnusson,  Carlos R. Moreira-Maia,  Maria Skoog,  Camilla Groth,  Donna Gillies,  Morris Zwi,  Richard Kirubakaran,  Christian Gluud and  Erik Simonsen  
Open Access
|Jul 2018

Authors

Erica Ramstad

erica_ramstad@hotmail.com

Psychiatric Research Unit, Region Zealand, Denmark
Child and Adolescent Psychiatric Department, Region Zealand, Denmark

Ole Jakob Storebø

Child and Adolescent Psychiatric Department, Region Zealand, Denmark
Department of Psychology, Faculty of Health Science, University of Southern Denmark, Odense, Denmark

Trine Gerner

Psychiatric Research Unit, Region Zealand, Denmark

Helle B. Krogh

Psychiatric Research Unit, Region Zealand, Denmark
Child and Adolescent Psychiatric Department, Region Zealand, Denmark

Mathilde Holmskov

Psychiatric Research Unit, Region Zealand, Denmark

Frederik L. Magnusson

Psychiatric Research Unit, Region Zealand, Denmark

Carlos R. Moreira-Maia

Federal University of Rio Grande do Sul, Porto Alegre, Brazil

Maria Skoog

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Camilla Groth

Pediatric Department E, Herlev University Hospital, Herlev, Denmark

Donna Gillies

Western Sydney Local Health District; Mental Health, Parramatta, Australia

Morris Zwi

Islington CAMHS, Whittington Health, Whittington, United-states

Richard Kirubakaran

Cochrane South Asia, Prof. BV Moses Center for Evidence-Informed Health Care and Health Policy, Christian Medical College, Vellore, India

Christian Gluud

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Erik Simonsen

Psychiatric Research Unit, Region Zealand, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
DOI: https://doi.org/10.21307/sjcapp-2018-003 | Journal eISSN: 2245-8875
Journal RSS Feed
Language: English
Page range: 52 - 71
Published on: Jul 10, 2018
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
adverse events,
attention-deficit/hyperactivity disorder,
methylphenidate,
psychotic symptoms
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2018 Erica Ramstad, Ole Jakob Storebø, Trine Gerner, Helle B. Krogh, Mathilde Holmskov, Frederik L. Magnusson, Carlos R. Moreira-Maia, Maria Skoog, Camilla Groth, Donna Gillies, Morris Zwi, Richard Kirubakaran, Christian Gluud, Erik Simonsen, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2018): Issue 1 (June 2018)Next article